<img alt="" height="1" width="1" />
Celgene enters field of cancer cell metabolism
Reuters
BOSTON, April 15 (Reuters) - Celgene Corp (CELG.O) said on Thursday it will pay $150 million for the option to develop and sell cancer drugs discovered by privately held Agios Pharmaceuticals Inc. Summit, New Jersey-based Celgene, ...
Celgene, Agios developing cancer treatmentsBusinessWeek
Agios scores $130M upfront from ambitious Celgene pactFierceBiotech
Celgene Pumps $130M Upfront into Agios Pharma for Drugs that Starve Cancer CellsXconomy
MarketWatch (press release)
all 36 news articles »
More...